SSL
Sasol Limited
NYSE · Basic Materials · Chemicals - Specialty · ZA
$12.26
−0.73%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 520.5B | 266.5B | 249.1B | 275.1B | 289.7B |
| Cost of Revenue | 348.6B | 184.4B | 143.1B | 153.4B | 167.4B |
| Gross Profit | 171.9B | 82.0B | 106.0B | 121.7B | 122.3B |
| Operating Expenses | |||||
| R&D Expense | — | 474.9M | — | — | — |
| SG&A Expense | 59.4B | 25.2B | 43.1B | 45.9B | 46.5B |
| General & Admin Expense | 25.6B | — | 33.5B | 35.5B | 36.0B |
| Selling & Marketing Expense | 9.6B | — | 9.6B | 10.4B | 10.5B |
| Other Expenses | 12.7B | 590.5M | 24.4B | 27.7B | — |
| Total Operating Expenses | 72.1B | 26.3B | 67.5B | 73.6B | 100.9B |
| Cost and Expenses | 420.7B | 210.7B | 210.6B | 227.0B | 268.3B |
| Operating Income (EBIT) | 99.8B | 55.8B | 38.5B | 48.1B | 54.5B |
| Non-Operating | |||||
| Interest Income | 3.6B | 2.3B | 2.9B | 3.2B | 6.9B |
| Interest Expense | 17.1B | 9.2B | 9.3B | 10.3B | — |
| Net Interest Income | (13.5B) | (6.9B) | (6.5B) | (7.0B) | 6.9B |
| Other Non-Op Income/Expense | (68.4B) | (37.6B) | (26.2B) | (82.6B) | 4.0B |
| Non-Operating Income (excl Interest) | 16.1B | — | 16.8B | 3.4B | 1.1B |
| EBT (Pre-Tax Income) | 31.4B | 18.2B | 12.3B | (34.5B) | 14.5B |
| Income Tax Expense | 8.8B | 4.1B | 4.6B | 9.7B | 5.2B |
| Bottom Line | |||||
| Net Income | 19.3B | 11.9B | 6.8B | (44.3B) | 8.8B |
| Earnings from Cont. Ops | 22.6B | 14.2B | 7.7B | (44.2B) | 41.7B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 19.3B | 11.9B | 6.8B | (44.3B) | 39.0B |
| Per Share | |||||
| Basic EPS | $29.71 | $18.54 | $10.56 | ($69.94) | $13.02 |
| Diluted EPS | $29.71 | $18.37 | $10.56 | ($69.94) | $13.02 |
| Revenue Per Share | $795.76 | $416.53 | $388.81 | $434.62 | $437.67 |
| Shares | |||||
| Basic Shares Outstanding | 654.1M | 639.7M | 640.7M | 633.0M | 661.9M |
| Diluted Shares Outstanding | 654.1M | 648.5M | 640.7M | 633.0M | 661.9M |
| Profitability Metrics | |||||
| EBITDA | 111.5B | 69.1B | 35.6B | 57.9B | 64.5B |
| D&A | 27.8B | 13.3B | 14.0B | 13.2B | 14.1B |
| EBIT | 83.7B | 55.8B | 21.6B | 44.7B | 50.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026